Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Clinton Severson currently holds 523,800 shares of RESPONSE BIOMEDICAL CORP (RBM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Clinton Severson has been a net seller of RBM stock. They have purchased $1.7M and sold $19.8M worth of shares.
Clinton Severson's most recent insider trade was on Jul 31, 2018, when they sold 523,800 shares at $83.00 per share.
Clinton Severson serves as Executive at RESPONSE BIOMEDICAL CORP (RBM). They have executed 397 insider transactions totaling $21.5M over their tenure at the company.
Clinton Severson holds the position of Executive at RESPONSE BIOMEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Clinton Severson has shown a selling trading pattern, with $1.7M in total purchases and $19.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Clinton Severson was on Jul 31, 2018, when they sold $43.5M worth of ABAX shares. This transaction involved 523,800 shares at $83.00 per share.
Clinton Severson currently owns 523,800 shares of RESPONSE BIOMEDICAL CORP (RBM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Clinton Severson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Clinton Severson has 397 Form 4 filings on record as an insider at RESPONSE BIOMEDICAL CORP.
Set alerts for Clinton Severson and 40,000+ other insiders.